nodes	percent_of_prediction	percent_of_DWPC	metapath
Bumetanide—SLC22A11—Doxycycline—malaria	0.189	0.288	CbGbCtD
Bumetanide—SLC22A8—Doxycycline—malaria	0.11	0.168	CbGbCtD
Bumetanide—SLCO1A2—Quinine—malaria	0.0859	0.131	CbGbCtD
Bumetanide—SLC22A6—Doxycycline—malaria	0.0767	0.117	CbGbCtD
Bumetanide—SLCO1A2—Quinidine—malaria	0.0755	0.115	CbGbCtD
Bumetanide—SLC22A8—Quinidine—malaria	0.0657	0.1	CbGbCtD
Bumetanide—PTGS2—Dapsone—malaria	0.0533	0.0812	CbGbCtD
Bumetanide—Arthritic pains—Quinidine barbiturate—malaria	0.0257	0.137	CcSEcCtD
Bumetanide—CA4—Erythrocytes take up carbon dioxide and release oxygen—SLC4A1—malaria	0.00809	0.147	CbGpPWpGaD
Bumetanide—Diuresis—Sulfadiazine—malaria	0.00758	0.0404	CcSEcCtD
Bumetanide—Amylase increased—Proguanil—malaria	0.00743	0.0397	CcSEcCtD
Bumetanide—CA4—Erythrocytes take up carbon dioxide and release oxygen—HBB—malaria	0.00688	0.125	CbGpPWpGaD
Bumetanide—Partial hearing loss—Quinidine—malaria	0.00568	0.0303	CcSEcCtD
Bumetanide—Partial hearing loss—Quinine—malaria	0.00568	0.0303	CcSEcCtD
Bumetanide—Partial hearing loss—Quinidine barbiturate—malaria	0.00513	0.0274	CcSEcCtD
Bumetanide—SLC12A1—blood plasma—malaria	0.00393	0.0389	CbGeAlD
Bumetanide—Azotaemia—Clindamycin—malaria	0.00328	0.0175	CcSEcCtD
Bumetanide—Azotaemia—Quinidine—malaria	0.00322	0.0172	CcSEcCtD
Bumetanide—Azotaemia—Quinine—malaria	0.00322	0.0172	CcSEcCtD
Bumetanide—SLC12A5—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC4A1—malaria	0.0031	0.0562	CbGpPWpGaD
Bumetanide—SLC12A4—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC4A1—malaria	0.0031	0.0562	CbGpPWpGaD
Bumetanide—CFTR—saliva-secreting gland—malaria	0.00309	0.0306	CbGeAlD
Bumetanide—Toxic epidermal necrolysis—Pyrimethamine—malaria	0.00297	0.0158	CcSEcCtD
Bumetanide—CFTR—hematopoietic system—malaria	0.00295	0.0292	CbGeAlD
Bumetanide—Azotaemia—Quinidine barbiturate—malaria	0.00291	0.0155	CcSEcCtD
Bumetanide—Blood disorder—Sulfadiazine—malaria	0.00281	0.015	CcSEcCtD
Bumetanide—SLC12A2—saliva-secreting gland—malaria	0.00272	0.0269	CbGeAlD
Bumetanide—SLC12A2—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC4A1—malaria	0.00264	0.0478	CbGpPWpGaD
Bumetanide—SLC12A2—hematopoietic system—malaria	0.00259	0.0257	CbGeAlD
Bumetanide—Stevens-Johnson syndrome—Pyrimethamine—malaria	0.00252	0.0134	CcSEcCtD
Bumetanide—CFTR—kidney—malaria	0.00242	0.024	CbGeAlD
Bumetanide—CA7—kidney—malaria	0.00238	0.0236	CbGeAlD
Bumetanide—CA5A—liver—malaria	0.00226	0.0224	CbGeAlD
Bumetanide—SLC12A1—hematopoietic system—malaria	0.00217	0.0215	CbGeAlD
Bumetanide—Erythema multiforme—Pyrimethamine—malaria	0.00216	0.0115	CcSEcCtD
Bumetanide—SLC12A2—kidney—malaria	0.00213	0.0211	CbGeAlD
Bumetanide—CFTR—digestive system—malaria	0.00205	0.0203	CbGeAlD
Bumetanide—Cholestasis—Pentoxifylline—malaria	0.00204	0.0109	CcSEcCtD
Bumetanide—CA7—digestive system—malaria	0.00202	0.02	CbGeAlD
Bumetanide—SLC10A1—kidney—malaria	0.00201	0.0199	CbGeAlD
Bumetanide—CFTR—blood—malaria	0.00196	0.0194	CbGeAlD
Bumetanide—SLC12A4—liver—malaria	0.00195	0.0193	CbGeAlD
Bumetanide—Polyuria—Sulfadiazine—malaria	0.00194	0.0104	CcSEcCtD
Bumetanide—SLC12A5—brain—malaria	0.00186	0.0184	CbGeAlD
Bumetanide—Liver injury—Quinidine barbiturate—malaria	0.00184	0.00982	CcSEcCtD
Bumetanide—SLC22A11—kidney—malaria	0.00183	0.0182	CbGeAlD
Bumetanide—SLC12A2—digestive system—malaria	0.0018	0.0179	CbGeAlD
Bumetanide—Hearing impaired—Quinine—malaria	0.0018	0.00962	CcSEcCtD
Bumetanide—Hearing impaired—Quinidine—malaria	0.0018	0.00962	CcSEcCtD
Bumetanide—SLC22A7—kidney—malaria	0.00179	0.0177	CbGeAlD
Bumetanide—SLC12A1—kidney—malaria	0.00178	0.0177	CbGeAlD
Bumetanide—Leukopenia—Pyrimethamine—malaria	0.00178	0.00949	CcSEcCtD
Bumetanide—CA9—digestive system—malaria	0.00178	0.0176	CbGeAlD
Bumetanide—SLC12A2—blood—malaria	0.00172	0.017	CbGeAlD
Bumetanide—SLC10A1—digestive system—malaria	0.0017	0.0169	CbGeAlD
Bumetanide—CA5B—hematopoietic system—malaria	0.00169	0.0168	CbGeAlD
Bumetanide—SLC12A2—bone marrow—malaria	0.00166	0.0165	CbGeAlD
Bumetanide—Hearing impaired—Quinidine barbiturate—malaria	0.00163	0.00868	CcSEcCtD
Bumetanide—Thrombocytopenia—Pyrimethamine—malaria	0.00159	0.00847	CcSEcCtD
Bumetanide—SLC12A1—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC4A1—malaria	0.00157	0.0284	CbGpPWpGaD
Bumetanide—SLC22A11—digestive system—malaria	0.00156	0.0154	CbGeAlD
Bumetanide—CA12—kidney—malaria	0.00155	0.0153	CbGeAlD
Bumetanide—Hepatocellular injury—Quinidine barbiturate—malaria	0.00155	0.00827	CcSEcCtD
Bumetanide—SLC12A4—brain—malaria	0.00155	0.0153	CbGeAlD
Bumetanide—Toxic epidermal necrolysis—Sulfadiazine—malaria	0.00154	0.0082	CcSEcCtD
Bumetanide—CFTR—liver—malaria	0.00153	0.0151	CbGeAlD
Bumetanide—SLC22A7—digestive system—malaria	0.00152	0.015	CbGeAlD
Bumetanide—PTGS2—endothelium—malaria	0.00146	0.0144	CbGeAlD
Bumetanide—Pancreatitis—Sulfadiazine—malaria	0.00144	0.00771	CcSEcCtD
Bumetanide—SLC12A1—blood—malaria	0.00144	0.0143	CbGeAlD
Bumetanide—SLC12A5—SLC-mediated transmembrane transport—SLC4A1—malaria	0.00139	0.0251	CbGpPWpGaD
Bumetanide—SLC12A4—SLC-mediated transmembrane transport—SLC4A1—malaria	0.00139	0.0251	CbGpPWpGaD
Bumetanide—SLC12A2—liver—malaria	0.00134	0.0133	CbGeAlD
Bumetanide—SLCO1A2—hematopoietic system—malaria	0.00132	0.0131	CbGeAlD
Bumetanide—CA12—digestive system—malaria	0.00131	0.013	CbGeAlD
Bumetanide—Stevens-Johnson syndrome—Sulfadiazine—malaria	0.0013	0.00695	CcSEcCtD
Bumetanide—PTGS2—blood plasma—malaria	0.0013	0.0128	CbGeAlD
Bumetanide—SLC10A1—liver—malaria	0.00127	0.0126	CbGeAlD
Bumetanide—SLC22A8—hematopoietic system—malaria	0.00126	0.0125	CbGeAlD
Bumetanide—CA14—liver—malaria	0.00126	0.0124	CbGeAlD
Bumetanide—CA4—saliva-secreting gland—malaria	0.00123	0.0121	CbGeAlD
Bumetanide—CFTR—brain—malaria	0.00121	0.012	CbGeAlD
Bumetanide—CA7—brain—malaria	0.0012	0.0118	CbGeAlD
Bumetanide—SLC12A2—SLC-mediated transmembrane transport—SLC4A1—malaria	0.00118	0.0214	CbGpPWpGaD
Bumetanide—SLC22A11—liver—malaria	0.00116	0.0115	CbGeAlD
Bumetanide—Cramp muscle—Clindamycin—malaria	0.00114	0.0061	CcSEcCtD
Bumetanide—Toxic epidermal necrolysis—Clindamycin—malaria	0.00114	0.0061	CcSEcCtD
Bumetanide—SLC22A7—liver—malaria	0.00113	0.0112	CbGeAlD
Bumetanide—CA5B—blood—malaria	0.00112	0.0111	CbGeAlD
Bumetanide—Toxic epidermal necrolysis—Quinine—malaria	0.00112	0.00599	CcSEcCtD
Bumetanide—Toxic epidermal necrolysis—Quinidine—malaria	0.00112	0.00599	CcSEcCtD
Bumetanide—Erythema multiforme—Sulfadiazine—malaria	0.00112	0.00595	CcSEcCtD
Bumetanide—Pancreatitis—Dapsone—malaria	0.00111	0.00594	CcSEcCtD
Bumetanide—SLCO1A2—kidney—malaria	0.00108	0.0107	CbGeAlD
Bumetanide—SLC12A2—brain—malaria	0.00107	0.0106	CbGeAlD
Bumetanide—Abdominal discomfort—Clindamycin—malaria	0.00105	0.00562	CcSEcCtD
Bumetanide—SLC22A8—kidney—malaria	0.00103	0.0102	CbGeAlD
Bumetanide—Gastrointestinal pain—Proguanil—malaria	0.00103	0.00551	CcSEcCtD
Bumetanide—Vomiting—Pyrimethamine—malaria	0.00103	0.0055	CcSEcCtD
Bumetanide—Toxic epidermal necrolysis—Quinidine barbiturate—malaria	0.00101	0.0054	CcSEcCtD
Bumetanide—SLC10A1—brain—malaria	0.00101	0.00998	CbGeAlD
Bumetanide—Abdominal pain—Proguanil—malaria	0.000998	0.00533	CcSEcCtD
Bumetanide—CA14—brain—malaria	0.000996	0.00986	CbGeAlD
Bumetanide—Stevens-Johnson syndrome—Clindamycin—malaria	0.00097	0.00518	CcSEcCtD
Bumetanide—CA4—kidney—malaria	0.000959	0.00949	CbGeAlD
Bumetanide—Stevens-Johnson syndrome—Quinine—malaria	0.000952	0.00508	CcSEcCtD
Bumetanide—Stevens-Johnson syndrome—Quinidine—malaria	0.000952	0.00508	CcSEcCtD
Bumetanide—SLC22A7—Fluoropyrimidine Activity—DHFR—malaria	0.000945	0.0171	CbGpPWpGaD
Bumetanide—Renal failure—Quinidine—malaria	0.000943	0.00504	CcSEcCtD
Bumetanide—Renal failure—Quinine—malaria	0.000943	0.00504	CcSEcCtD
Bumetanide—Abdominal discomfort—Pentoxifylline—malaria	0.00093	0.00496	CcSEcCtD
Bumetanide—Vertigo—Sulfadiazine—malaria	0.000922	0.00492	CcSEcCtD
Bumetanide—Sweating—Quinine—malaria	0.00092	0.00491	CcSEcCtD
Bumetanide—Sweating—Quinidine—malaria	0.00092	0.00491	CcSEcCtD
Bumetanide—SLCO1A2—digestive system—malaria	0.00092	0.0091	CbGeAlD
Bumetanide—Leukopenia—Sulfadiazine—malaria	0.000919	0.00491	CcSEcCtD
Bumetanide—PTGS2—Synthesis of Prostaglandins (PG) and Thromboxanes (TX)—HPGDS—malaria	0.000912	0.0165	CbGpPWpGaD
Bumetanide—SLC22A7—brain—malaria	0.000898	0.00889	CbGeAlD
Bumetanide—SLC12A1—brain—malaria	0.000894	0.00885	CbGeAlD
Bumetanide—Arthralgia—Sulfadiazine—malaria	0.000874	0.00467	CcSEcCtD
Bumetanide—SLC22A6—brain—malaria	0.000867	0.00858	CbGeAlD
Bumetanide—Diarrhoea—Proguanil—malaria	0.000864	0.00461	CcSEcCtD
Bumetanide—Stevens-Johnson syndrome—Quinidine barbiturate—malaria	0.000859	0.00458	CcSEcCtD
Bumetanide—Renal failure—Quinidine barbiturate—malaria	0.000851	0.00455	CcSEcCtD
Bumetanide—SLC22A8—blood—malaria	0.000836	0.00828	CbGeAlD
Bumetanide—Erythema multiforme—Clindamycin—malaria	0.00083	0.00443	CcSEcCtD
Bumetanide—Sweating—Quinidine barbiturate—malaria	0.00083	0.00443	CcSEcCtD
Bumetanide—Sweating—Pentoxifylline—malaria	0.000829	0.00443	CcSEcCtD
Bumetanide—Thrombocytopenia—Sulfadiazine—malaria	0.00082	0.00438	CcSEcCtD
Bumetanide—Erythema multiforme—Quinine—malaria	0.000815	0.00435	CcSEcCtD
Bumetanide—Erythema multiforme—Quinidine—malaria	0.000815	0.00435	CcSEcCtD
Bumetanide—CA4—digestive system—malaria	0.000813	0.00805	CbGeAlD
Bumetanide—Vomiting—Proguanil—malaria	0.000803	0.00428	CcSEcCtD
Bumetanide—Rash—Proguanil—malaria	0.000796	0.00425	CcSEcCtD
Bumetanide—Dermatitis—Proguanil—malaria	0.000795	0.00425	CcSEcCtD
Bumetanide—Headache—Proguanil—malaria	0.000791	0.00422	CcSEcCtD
Bumetanide—CA12—brain—malaria	0.000777	0.00769	CbGeAlD
Bumetanide—CA4—blood—malaria	0.000775	0.00767	CbGeAlD
Bumetanide—CA4—bone marrow—malaria	0.00075	0.00743	CbGeAlD
Bumetanide—Nausea—Proguanil—malaria	0.00075	0.004	CcSEcCtD
Bumetanide—Erythema multiforme—Quinidine barbiturate—malaria	0.000735	0.00392	CcSEcCtD
Bumetanide—Muscle spasms—Clindamycin—malaria	0.000735	0.00392	CcSEcCtD
Bumetanide—PTGS2—hematopoietic system—malaria	0.000716	0.00709	CbGeAlD
Bumetanide—Vertigo—Dapsone—malaria	0.00071	0.00379	CcSEcCtD
Bumetanide—SLC12A5—Transmembrane transport of small molecules—SLC4A1—malaria	0.000704	0.0128	CbGpPWpGaD
Bumetanide—CFTR—Transmembrane transport of small molecules—SLC4A1—malaria	0.000704	0.0128	CbGpPWpGaD
Bumetanide—SLC12A4—Transmembrane transport of small molecules—SLC4A1—malaria	0.000704	0.0128	CbGpPWpGaD
Bumetanide—SLC12A1—SLC-mediated transmembrane transport—SLC4A1—malaria	0.000701	0.0127	CbGpPWpGaD
Bumetanide—CA5B—brain—malaria	0.000697	0.0069	CbGeAlD
Bumetanide—Vertigo—Clindamycin—malaria	0.000687	0.00367	CcSEcCtD
Bumetanide—Gastrointestinal pain—Sulfadiazine—malaria	0.000685	0.00366	CcSEcCtD
Bumetanide—SLCO1A2—liver—malaria	0.000685	0.00678	CbGeAlD
Bumetanide—Leukopenia—Clindamycin—malaria	0.000684	0.00365	CcSEcCtD
Bumetanide—Vertigo—Quinine—malaria	0.000674	0.0036	CcSEcCtD
Bumetanide—Vertigo—Quinidine—malaria	0.000674	0.0036	CcSEcCtD
Bumetanide—Leukopenia—Quinidine—malaria	0.000671	0.00358	CcSEcCtD
Bumetanide—Leukopenia—Quinine—malaria	0.000671	0.00358	CcSEcCtD
Bumetanide—Urticaria—Sulfadiazine—malaria	0.000666	0.00355	CcSEcCtD
Bumetanide—Abdominal pain—Sulfadiazine—malaria	0.000662	0.00354	CcSEcCtD
Bumetanide—Muscle spasms—Pentoxifylline—malaria	0.00065	0.00347	CcSEcCtD
Bumetanide—Chest pain—Quinidine—malaria	0.000639	0.00341	CcSEcCtD
Bumetanide—Chest pain—Quinine—malaria	0.000639	0.00341	CcSEcCtD
Bumetanide—Thrombocytopenia—Clindamycin—malaria	0.000611	0.00326	CcSEcCtD
Bumetanide—Vertigo—Quinidine barbiturate—malaria	0.000608	0.00325	CcSEcCtD
Bumetanide—Leukopenia—Quinidine barbiturate—malaria	0.000606	0.00323	CcSEcCtD
Bumetanide—Leukopenia—Pentoxifylline—malaria	0.000605	0.00323	CcSEcCtD
Bumetanide—Thrombocytopenia—Quinine—malaria	0.000599	0.0032	CcSEcCtD
Bumetanide—Thrombocytopenia—Quinidine—malaria	0.000599	0.0032	CcSEcCtD
Bumetanide—SLC12A2—Transmembrane transport of small molecules—SLC4A1—malaria	0.000599	0.0109	CbGpPWpGaD
Bumetanide—Pruritus—Sulfadiazine—malaria	0.000593	0.00316	CcSEcCtD
Bumetanide—Hyperhidrosis—Quinidine—malaria	0.000592	0.00316	CcSEcCtD
Bumetanide—Hyperhidrosis—Quinine—malaria	0.000592	0.00316	CcSEcCtD
Bumetanide—PTGS2—kidney—malaria	0.000587	0.00581	CbGeAlD
Bumetanide—Hypotension—Clindamycin—malaria	0.000583	0.00311	CcSEcCtD
Bumetanide—Chest pain—Quinidine barbiturate—malaria	0.000576	0.00308	CcSEcCtD
Bumetanide—Arthralgia—Quinidine barbiturate—malaria	0.000576	0.00308	CcSEcCtD
Bumetanide—Chest pain—Pentoxifylline—malaria	0.000575	0.00307	CcSEcCtD
Bumetanide—Diarrhoea—Sulfadiazine—malaria	0.000573	0.00306	CcSEcCtD
Bumetanide—Hypotension—Quinine—malaria	0.000572	0.00305	CcSEcCtD
Bumetanide—Hypotension—Quinidine—malaria	0.000572	0.00305	CcSEcCtD
Bumetanide—Dry mouth—Pentoxifylline—malaria	0.000563	0.003	CcSEcCtD
Bumetanide—SLCO1A2—brain—malaria	0.000544	0.00538	CbGeAlD
Bumetanide—Thrombocytopenia—Quinidine barbiturate—malaria	0.000541	0.00289	CcSEcCtD
Bumetanide—Thrombocytopenia—Pentoxifylline—malaria	0.00054	0.00288	CcSEcCtD
Bumetanide—Fatigue—Clindamycin—malaria	0.000538	0.00287	CcSEcCtD
Bumetanide—Hyperhidrosis—Quinidine barbiturate—malaria	0.000534	0.00285	CcSEcCtD
Bumetanide—Hyperhidrosis—Pentoxifylline—malaria	0.000533	0.00285	CcSEcCtD
Bumetanide—Vomiting—Sulfadiazine—malaria	0.000533	0.00284	CcSEcCtD
Bumetanide—Rash—Sulfadiazine—malaria	0.000528	0.00282	CcSEcCtD
Bumetanide—Dermatitis—Sulfadiazine—malaria	0.000528	0.00282	CcSEcCtD
Bumetanide—Gastrointestinal pain—Dapsone—malaria	0.000527	0.00282	CcSEcCtD
Bumetanide—Headache—Sulfadiazine—malaria	0.000525	0.0028	CcSEcCtD
Bumetanide—SLC22A8—brain—malaria	0.000519	0.00514	CbGeAlD
Bumetanide—Hypotension—Quinidine barbiturate—malaria	0.000516	0.00276	CcSEcCtD
Bumetanide—Hypotension—Pentoxifylline—malaria	0.000515	0.00275	CcSEcCtD
Bumetanide—Gastrointestinal pain—Clindamycin—malaria	0.00051	0.00272	CcSEcCtD
Bumetanide—Abdominal pain—Dapsone—malaria	0.00051	0.00272	CcSEcCtD
Bumetanide—Gastrointestinal pain—Quinine—malaria	0.000501	0.00267	CcSEcCtD
Bumetanide—Gastrointestinal pain—Quinidine—malaria	0.000501	0.00267	CcSEcCtD
Bumetanide—PTGS2—digestive system—malaria	0.000498	0.00493	CbGeAlD
Bumetanide—Nausea—Sulfadiazine—malaria	0.000498	0.00266	CcSEcCtD
Bumetanide—Urticaria—Clindamycin—malaria	0.000496	0.00265	CcSEcCtD
Bumetanide—Abdominal pain—Clindamycin—malaria	0.000493	0.00263	CcSEcCtD
Bumetanide—Urticaria—Quinidine—malaria	0.000486	0.0026	CcSEcCtD
Bumetanide—Urticaria—Quinine—malaria	0.000486	0.0026	CcSEcCtD
Bumetanide—Abdominal pain—Quinine—malaria	0.000484	0.00258	CcSEcCtD
Bumetanide—Abdominal pain—Quinidine—malaria	0.000484	0.00258	CcSEcCtD
Bumetanide—CA4—brain—malaria	0.000481	0.00476	CbGeAlD
Bumetanide—PTGS2—blood—malaria	0.000474	0.0047	CbGeAlD
Bumetanide—PTGS2—bone marrow—malaria	0.000459	0.00455	CbGeAlD
Bumetanide—Gastrointestinal pain—Quinidine barbiturate—malaria	0.000452	0.00241	CcSEcCtD
Bumetanide—Gastrointestinal pain—Pentoxifylline—malaria	0.000451	0.00241	CcSEcCtD
Bumetanide—Asthenia—Clindamycin—malaria	0.000448	0.00239	CcSEcCtD
Bumetanide—Pruritus—Clindamycin—malaria	0.000441	0.00236	CcSEcCtD
Bumetanide—Asthenia—Quinine—malaria	0.000439	0.00234	CcSEcCtD
Bumetanide—Asthenia—Quinidine—malaria	0.000439	0.00234	CcSEcCtD
Bumetanide—Urticaria—Quinidine barbiturate—malaria	0.000439	0.00234	CcSEcCtD
Bumetanide—Urticaria—Pentoxifylline—malaria	0.000438	0.00234	CcSEcCtD
Bumetanide—Abdominal pain—Quinidine barbiturate—malaria	0.000437	0.00233	CcSEcCtD
Bumetanide—Abdominal pain—Pentoxifylline—malaria	0.000436	0.00233	CcSEcCtD
Bumetanide—Pruritus—Quinine—malaria	0.000433	0.00231	CcSEcCtD
Bumetanide—Pruritus—Quinidine—malaria	0.000433	0.00231	CcSEcCtD
Bumetanide—Diarrhoea—Clindamycin—malaria	0.000427	0.00228	CcSEcCtD
Bumetanide—Diarrhoea—Quinidine—malaria	0.000419	0.00224	CcSEcCtD
Bumetanide—Diarrhoea—Quinine—malaria	0.000419	0.00224	CcSEcCtD
Bumetanide—SLC22A11—SLC-mediated transmembrane transport—SLC4A1—malaria	0.000418	0.00758	CbGpPWpGaD
Bumetanide—Dizziness—Clindamycin—malaria	0.000413	0.0022	CcSEcCtD
Bumetanide—Vomiting—Dapsone—malaria	0.00041	0.00219	CcSEcCtD
Bumetanide—Dizziness—Quinidine—malaria	0.000405	0.00216	CcSEcCtD
Bumetanide—Dizziness—Quinine—malaria	0.000405	0.00216	CcSEcCtD
Bumetanide—Headache—Dapsone—malaria	0.000404	0.00216	CcSEcCtD
Bumetanide—Vomiting—Clindamycin—malaria	0.000397	0.00212	CcSEcCtD
Bumetanide—Asthenia—Quinidine barbiturate—malaria	0.000396	0.00212	CcSEcCtD
Bumetanide—Asthenia—Pentoxifylline—malaria	0.000396	0.00211	CcSEcCtD
Bumetanide—Rash—Clindamycin—malaria	0.000393	0.0021	CcSEcCtD
Bumetanide—Dermatitis—Clindamycin—malaria	0.000393	0.0021	CcSEcCtD
Bumetanide—Headache—Clindamycin—malaria	0.000391	0.00209	CcSEcCtD
Bumetanide—Pruritus—Quinidine barbiturate—malaria	0.000391	0.00209	CcSEcCtD
Bumetanide—Pruritus—Pentoxifylline—malaria	0.00039	0.00208	CcSEcCtD
Bumetanide—Vomiting—Quinidine—malaria	0.000389	0.00208	CcSEcCtD
Bumetanide—Vomiting—Quinine—malaria	0.000389	0.00208	CcSEcCtD
Bumetanide—Rash—Quinine—malaria	0.000386	0.00206	CcSEcCtD
Bumetanide—Rash—Quinidine—malaria	0.000386	0.00206	CcSEcCtD
Bumetanide—Dermatitis—Quinine—malaria	0.000386	0.00206	CcSEcCtD
Bumetanide—Dermatitis—Quinidine—malaria	0.000386	0.00206	CcSEcCtD
Bumetanide—Headache—Quinine—malaria	0.000383	0.00205	CcSEcCtD
Bumetanide—Headache—Quinidine—malaria	0.000383	0.00205	CcSEcCtD
Bumetanide—Nausea—Dapsone—malaria	0.000383	0.00205	CcSEcCtD
Bumetanide—SLC22A7—SLC-mediated transmembrane transport—SLC4A1—malaria	0.000379	0.00688	CbGpPWpGaD
Bumetanide—Diarrhoea—Quinidine barbiturate—malaria	0.000378	0.00202	CcSEcCtD
Bumetanide—Diarrhoea—Pentoxifylline—malaria	0.000377	0.00201	CcSEcCtD
Bumetanide—PTGS2—liver—malaria	0.000371	0.00367	CbGeAlD
Bumetanide—PTGS2—Overview of nanoparticle effects—CRP—malaria	0.000371	0.00673	CbGpPWpGaD
Bumetanide—Nausea—Clindamycin—malaria	0.000371	0.00198	CcSEcCtD
Bumetanide—Dizziness—Quinidine barbiturate—malaria	0.000365	0.00195	CcSEcCtD
Bumetanide—Dizziness—Pentoxifylline—malaria	0.000365	0.00195	CcSEcCtD
Bumetanide—Nausea—Quinidine—malaria	0.000364	0.00194	CcSEcCtD
Bumetanide—Nausea—Quinine—malaria	0.000364	0.00194	CcSEcCtD
Bumetanide—SLC12A1—Transmembrane transport of small molecules—SLC4A1—malaria	0.000356	0.00646	CbGpPWpGaD
Bumetanide—PTGS2—S1P1 pathway—KDR—malaria	0.000356	0.00645	CbGpPWpGaD
Bumetanide—PTGS2—Aryl Hydrocarbon Receptor—HPGDS—malaria	0.000352	0.00638	CbGpPWpGaD
Bumetanide—Vomiting—Quinidine barbiturate—malaria	0.000351	0.00188	CcSEcCtD
Bumetanide—Vomiting—Pentoxifylline—malaria	0.000351	0.00187	CcSEcCtD
Bumetanide—Rash—Quinidine barbiturate—malaria	0.000348	0.00186	CcSEcCtD
Bumetanide—Dermatitis—Quinidine barbiturate—malaria	0.000348	0.00186	CcSEcCtD
Bumetanide—Rash—Pentoxifylline—malaria	0.000348	0.00186	CcSEcCtD
Bumetanide—Dermatitis—Pentoxifylline—malaria	0.000347	0.00185	CcSEcCtD
Bumetanide—Headache—Quinidine barbiturate—malaria	0.000346	0.00185	CcSEcCtD
Bumetanide—PTGS2—Selenium Micronutrient Network—HBB—malaria	0.000346	0.00627	CbGpPWpGaD
Bumetanide—Headache—Pentoxifylline—malaria	0.000345	0.00184	CcSEcCtD
Bumetanide—PTGS2—Arachidonic acid metabolism—HPGDS—malaria	0.000329	0.00597	CbGpPWpGaD
Bumetanide—Nausea—Quinidine barbiturate—malaria	0.000328	0.00175	CcSEcCtD
Bumetanide—Nausea—Pentoxifylline—malaria	0.000328	0.00175	CcSEcCtD
Bumetanide—CA9—HIF-1-alpha transcription factor network—NOS2—malaria	0.000324	0.00588	CbGpPWpGaD
Bumetanide—SLC22A8—SLC-mediated transmembrane transport—SLC4A1—malaria	0.000319	0.00578	CbGpPWpGaD
Bumetanide—PTGS2—Calcium signaling in the CD4+ TCR pathway—CD40LG—malaria	0.000315	0.0057	CbGpPWpGaD
Bumetanide—PTGS2—Calcium signaling in the CD4+ TCR pathway—IL4—malaria	0.000306	0.00555	CbGpPWpGaD
Bumetanide—PTGS2—brain—malaria	0.000294	0.00291	CbGeAlD
Bumetanide—SLC10A1—Metabolism of lipids and lipoproteins—DECR1—malaria	0.000289	0.00524	CbGpPWpGaD
Bumetanide—SLCO1A2—SLC-mediated transmembrane transport—SLC4A1—malaria	0.000283	0.00513	CbGpPWpGaD
Bumetanide—SLC22A6—SLC-mediated transmembrane transport—SLC4A1—malaria	0.000266	0.00482	CbGpPWpGaD
Bumetanide—CA14—Metabolism—DHODH—malaria	0.000229	0.00414	CbGpPWpGaD
Bumetanide—CA5A—Metabolism—DHODH—malaria	0.000223	0.00404	CbGpPWpGaD
Bumetanide—SLC22A11—Transmembrane transport of small molecules—SLC4A1—malaria	0.000212	0.00385	CbGpPWpGaD
Bumetanide—CA7—Metabolism—DHODH—malaria	0.000208	0.00377	CbGpPWpGaD
Bumetanide—CA5B—Metabolism—DHODH—malaria	0.000208	0.00377	CbGpPWpGaD
Bumetanide—PTGS2—Signaling mediated by p38-alpha and p38-beta—NOS2—malaria	0.000207	0.00376	CbGpPWpGaD
Bumetanide—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CD40LG—malaria	0.000203	0.00369	CbGpPWpGaD
Bumetanide—PTGS2—Aryl Hydrocarbon Receptor—CD36—malaria	0.000203	0.00368	CbGpPWpGaD
Bumetanide—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL4—malaria	0.000198	0.00359	CbGpPWpGaD
Bumetanide—PTGS2—Defective AMN causes hereditary megaloblastic anemia 1—DHFR—malaria	0.000196	0.00356	CbGpPWpGaD
Bumetanide—CA14—Metabolism—SLC4A1—malaria	0.000194	0.00352	CbGpPWpGaD
Bumetanide—SLC22A7—Transmembrane transport of small molecules—SLC4A1—malaria	0.000193	0.0035	CbGpPWpGaD
Bumetanide—CA12—Metabolism—DHODH—malaria	0.000193	0.00349	CbGpPWpGaD
Bumetanide—PTGS2—Selenium Micronutrient Network—SCARB1—malaria	0.000192	0.00349	CbGpPWpGaD
Bumetanide—CA5A—Metabolism—SLC4A1—malaria	0.000189	0.00343	CbGpPWpGaD
Bumetanide—PTGS2—Calcium signaling in the CD4+ TCR pathway—IFNG—malaria	0.000185	0.00335	CbGpPWpGaD
Bumetanide—CA14—Metabolism—DECR1—malaria	0.000183	0.00331	CbGpPWpGaD
Bumetanide—CA5A—Metabolism—DECR1—malaria	0.000178	0.00323	CbGpPWpGaD
Bumetanide—CA5B—Metabolism—SLC4A1—malaria	0.000177	0.00321	CbGpPWpGaD
Bumetanide—CA7—Metabolism—SLC4A1—malaria	0.000177	0.00321	CbGpPWpGaD
Bumetanide—PTGS2—Overview of nanoparticle effects—TNF—malaria	0.000168	0.00304	CbGpPWpGaD
Bumetanide—CA7—Metabolism—DECR1—malaria	0.000166	0.00301	CbGpPWpGaD
Bumetanide—CA5B—Metabolism—DECR1—malaria	0.000166	0.00301	CbGpPWpGaD
Bumetanide—PTGS2—Spinal Cord Injury—FCGR2A—malaria	0.000166	0.003	CbGpPWpGaD
Bumetanide—CA14—Metabolism—HBB—malaria	0.000165	0.003	CbGpPWpGaD
Bumetanide—PTGS2—Calcium signaling in the CD4+ TCR pathway—IL2—malaria	0.000164	0.00298	CbGpPWpGaD
Bumetanide—CA12—Metabolism—SLC4A1—malaria	0.000164	0.00297	CbGpPWpGaD
Bumetanide—SLC22A8—Transmembrane transport of small molecules—SLC4A1—malaria	0.000162	0.00294	CbGpPWpGaD
Bumetanide—CA5A—Metabolism—HBB—malaria	0.000161	0.00292	CbGpPWpGaD
Bumetanide—SLC10A1—Metabolism—DHODH—malaria	0.000161	0.00292	CbGpPWpGaD
Bumetanide—SLC10A1—Metabolism of lipids and lipoproteins—HPGDS—malaria	0.000158	0.00287	CbGpPWpGaD
Bumetanide—CA12—Metabolism—DECR1—malaria	0.000154	0.00279	CbGpPWpGaD
Bumetanide—CA4—Metabolism—DHODH—malaria	0.000154	0.00279	CbGpPWpGaD
Bumetanide—CA5B—Metabolism—HBB—malaria	0.00015	0.00273	CbGpPWpGaD
Bumetanide—CA7—Metabolism—HBB—malaria	0.00015	0.00273	CbGpPWpGaD
Bumetanide—CA14—Metabolism—PKLR—malaria	0.000147	0.00267	CbGpPWpGaD
Bumetanide—SLC10A1—Metabolism of lipids and lipoproteins—SCARB1—malaria	0.000145	0.00264	CbGpPWpGaD
Bumetanide—SLCO1A2—Transmembrane transport of small molecules—SLC4A1—malaria	0.000144	0.00261	CbGpPWpGaD
Bumetanide—CA5A—Metabolism—PKLR—malaria	0.000144	0.0026	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism of lipids and lipoproteins—DECR1—malaria	0.000142	0.00258	CbGpPWpGaD
Bumetanide—CA12—Metabolism—HBB—malaria	0.000139	0.00253	CbGpPWpGaD
Bumetanide—SLC10A1—Metabolism—SLC4A1—malaria	0.000137	0.00248	CbGpPWpGaD
Bumetanide—PTGS2—Overview of nanoparticle effects—IL6—malaria	0.000136	0.00246	CbGpPWpGaD
Bumetanide—SLC22A6—Transmembrane transport of small molecules—SLC4A1—malaria	0.000135	0.00245	CbGpPWpGaD
Bumetanide—CA5B—Metabolism—PKLR—malaria	0.000134	0.00243	CbGpPWpGaD
Bumetanide—CA7—Metabolism—PKLR—malaria	0.000134	0.00243	CbGpPWpGaD
Bumetanide—CA14—Metabolism—G6PD—malaria	0.000131	0.00238	CbGpPWpGaD
Bumetanide—CA4—Metabolism—SLC4A1—malaria	0.000131	0.00237	CbGpPWpGaD
Bumetanide—SLC10A1—Metabolism—DECR1—malaria	0.000129	0.00233	CbGpPWpGaD
Bumetanide—CA5A—Metabolism—G6PD—malaria	0.000128	0.00232	CbGpPWpGaD
Bumetanide—CA12—Metabolism—PKLR—malaria	0.000124	0.00225	CbGpPWpGaD
Bumetanide—CA9—Metabolism—DHODH—malaria	0.000124	0.00225	CbGpPWpGaD
Bumetanide—CA4—Metabolism—DECR1—malaria	0.000123	0.00223	CbGpPWpGaD
Bumetanide—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IFNG—malaria	0.00012	0.00217	CbGpPWpGaD
Bumetanide—CA5B—Metabolism—G6PD—malaria	0.000119	0.00217	CbGpPWpGaD
Bumetanide—CA7—Metabolism—G6PD—malaria	0.000119	0.00217	CbGpPWpGaD
Bumetanide—SLC10A1—Metabolism—HBB—malaria	0.000116	0.00211	CbGpPWpGaD
Bumetanide—PTGS2—Integrated Pancreatic Cancer Pathway—HPGDS—malaria	0.000113	0.00204	CbGpPWpGaD
Bumetanide—CA4—Metabolism—HBB—malaria	0.000111	0.00201	CbGpPWpGaD
Bumetanide—CA12—Metabolism—G6PD—malaria	0.000111	0.00201	CbGpPWpGaD
Bumetanide—PTGS2—Selenium Micronutrient Network—CRP—malaria	0.000109	0.00197	CbGpPWpGaD
Bumetanide—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL2—malaria	0.000106	0.00193	CbGpPWpGaD
Bumetanide—CA9—Metabolism—SLC4A1—malaria	0.000106	0.00191	CbGpPWpGaD
Bumetanide—SLC10A1—Metabolism—PKLR—malaria	0.000104	0.00188	CbGpPWpGaD
Bumetanide—CA14—Metabolism—HPGDS—malaria	0.0001	0.00182	CbGpPWpGaD
Bumetanide—PTGS2—Selenium Micronutrient Network—ICAM1—malaria	0.0001	0.00181	CbGpPWpGaD
Bumetanide—PTGS2—Spinal Cord Injury—IL4—malaria	9.96e-05	0.00181	CbGpPWpGaD
Bumetanide—CA9—Metabolism—DECR1—malaria	9.92e-05	0.0018	CbGpPWpGaD
Bumetanide—CA4—Metabolism—PKLR—malaria	9.9e-05	0.0018	CbGpPWpGaD
Bumetanide—CA5A—Metabolism—HPGDS—malaria	9.76e-05	0.00177	CbGpPWpGaD
Bumetanide—CA14—Metabolism—DHFR—malaria	9.29e-05	0.00168	CbGpPWpGaD
Bumetanide—SLC10A1—Metabolism—G6PD—malaria	9.25e-05	0.00168	CbGpPWpGaD
Bumetanide—CA14—Metabolism—SCARB1—malaria	9.19e-05	0.00167	CbGpPWpGaD
Bumetanide—SLC10A1—Metabolism of lipids and lipoproteins—CD36—malaria	9.13e-05	0.00165	CbGpPWpGaD
Bumetanide—CA7—Metabolism—HPGDS—malaria	9.11e-05	0.00165	CbGpPWpGaD
Bumetanide—CA5B—Metabolism—HPGDS—malaria	9.11e-05	0.00165	CbGpPWpGaD
Bumetanide—CA5A—Metabolism—DHFR—malaria	9.05e-05	0.00164	CbGpPWpGaD
Bumetanide—CA9—Metabolism—HBB—malaria	8.98e-05	0.00163	CbGpPWpGaD
Bumetanide—CA5A—Metabolism—SCARB1—malaria	8.96e-05	0.00162	CbGpPWpGaD
Bumetanide—CA4—Metabolism—G6PD—malaria	8.82e-05	0.0016	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism of lipids and lipoproteins—DECR1—malaria	8.59e-05	0.00156	CbGpPWpGaD
Bumetanide—CA7—Metabolism—DHFR—malaria	8.45e-05	0.00153	CbGpPWpGaD
Bumetanide—CA5B—Metabolism—DHFR—malaria	8.45e-05	0.00153	CbGpPWpGaD
Bumetanide—CA12—Metabolism—HPGDS—malaria	8.44e-05	0.00153	CbGpPWpGaD
Bumetanide—CA7—Metabolism—SCARB1—malaria	8.36e-05	0.00152	CbGpPWpGaD
Bumetanide—CA5B—Metabolism—SCARB1—malaria	8.36e-05	0.00152	CbGpPWpGaD
Bumetanide—PTGS2—Aryl Hydrocarbon Receptor—TNF—malaria	8.28e-05	0.0015	CbGpPWpGaD
Bumetanide—PTGS2—Spinal Cord Injury—TLR4—malaria	8.25e-05	0.0015	CbGpPWpGaD
Bumetanide—CA9—Metabolism—PKLR—malaria	8e-05	0.00145	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism—DHODH—malaria	7.92e-05	0.00144	CbGpPWpGaD
Bumetanide—PTGS2—Spinal Cord Injury—ICAM1—malaria	7.91e-05	0.00143	CbGpPWpGaD
Bumetanide—PTGS2—Spinal Cord Injury—NOS2—malaria	7.85e-05	0.00142	CbGpPWpGaD
Bumetanide—CA12—Metabolism—DHFR—malaria	7.83e-05	0.00142	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism of lipids and lipoproteins—HPGDS—malaria	7.79e-05	0.00141	CbGpPWpGaD
Bumetanide—CA12—Metabolism—SCARB1—malaria	7.75e-05	0.0014	CbGpPWpGaD
Bumetanide—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—malaria	7.74e-05	0.0014	CbGpPWpGaD
Bumetanide—PTGS2—C-MYB transcription factor network—CD4—malaria	7.63e-05	0.00138	CbGpPWpGaD
Bumetanide—PTGS2—Selenium Micronutrient Network—IFNG—malaria	7.61e-05	0.00138	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism of lipids and lipoproteins—SCARB1—malaria	7.16e-05	0.0013	CbGpPWpGaD
Bumetanide—CA9—Metabolism—G6PD—malaria	7.13e-05	0.00129	CbGpPWpGaD
Bumetanide—SLC10A1—Metabolism—HPGDS—malaria	7.05e-05	0.00128	CbGpPWpGaD
Bumetanide—PTGS2—Selenium Micronutrient Network—IL1B—malaria	6.79e-05	0.00123	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism—SLC4A1—malaria	6.74e-05	0.00122	CbGpPWpGaD
Bumetanide—CA4—Metabolism—HPGDS—malaria	6.73e-05	0.00122	CbGpPWpGaD
Bumetanide—SLC10A1—Metabolism—DHFR—malaria	6.54e-05	0.00119	CbGpPWpGaD
Bumetanide—SLC10A1—Metabolism—SCARB1—malaria	6.48e-05	0.00117	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism—DECR1—malaria	6.33e-05	0.00115	CbGpPWpGaD
Bumetanide—CA4—Metabolism—DHFR—malaria	6.24e-05	0.00113	CbGpPWpGaD
Bumetanide—PTGS2—Integrated Pancreatic Cancer Pathway—FAS—malaria	6.24e-05	0.00113	CbGpPWpGaD
Bumetanide—CA4—Metabolism—SCARB1—malaria	6.18e-05	0.00112	CbGpPWpGaD
Bumetanide—PTGS2—Spinal Cord Injury—IFNG—malaria	6.02e-05	0.00109	CbGpPWpGaD
Bumetanide—CA14—Metabolism—CD36—malaria	5.77e-05	0.00105	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism—HBB—malaria	5.73e-05	0.00104	CbGpPWpGaD
Bumetanide—CA5A—Metabolism—CD36—malaria	5.62e-05	0.00102	CbGpPWpGaD
Bumetanide—CA9—Metabolism—HPGDS—malaria	5.44e-05	0.000986	CbGpPWpGaD
Bumetanide—PTGS2—Spinal Cord Injury—IL1B—malaria	5.37e-05	0.000974	CbGpPWpGaD
Bumetanide—PTGS2—Spinal Cord Injury—IL2—malaria	5.35e-05	0.00097	CbGpPWpGaD
Bumetanide—CA7—Metabolism—CD36—malaria	5.25e-05	0.000952	CbGpPWpGaD
Bumetanide—CA5B—Metabolism—CD36—malaria	5.25e-05	0.000952	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism—PKLR—malaria	5.11e-05	0.000926	CbGpPWpGaD
Bumetanide—CA9—Metabolism—DHFR—malaria	5.04e-05	0.000915	CbGpPWpGaD
Bumetanide—CA9—Metabolism—SCARB1—malaria	4.99e-05	0.000905	CbGpPWpGaD
Bumetanide—PTGS2—Selenium Micronutrient Network—TNF—malaria	4.93e-05	0.000893	CbGpPWpGaD
Bumetanide—CA12—Metabolism—CD36—malaria	4.86e-05	0.000882	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—DHODH—malaria	4.79e-05	0.000868	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism of lipids and lipoproteins—HPGDS—malaria	4.71e-05	0.000853	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism—G6PD—malaria	4.55e-05	0.000825	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism of lipids and lipoproteins—CD36—malaria	4.49e-05	0.000814	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism of lipids and lipoproteins—SCARB1—malaria	4.32e-05	0.000784	CbGpPWpGaD
Bumetanide—CA9—Cellular responses to stress—IL6—malaria	4.28e-05	0.000777	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—SLC4A1—malaria	4.07e-05	0.000738	CbGpPWpGaD
Bumetanide—SLC10A1—Metabolism—CD36—malaria	4.06e-05	0.000737	CbGpPWpGaD
Bumetanide—PTGS2—Selenium Micronutrient Network—IL6—malaria	3.98e-05	0.000721	CbGpPWpGaD
Bumetanide—PTGS2—Spinal Cord Injury—TNF—malaria	3.9e-05	0.000706	CbGpPWpGaD
Bumetanide—CA4—Metabolism—CD36—malaria	3.88e-05	0.000703	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—DECR1—malaria	3.83e-05	0.000694	CbGpPWpGaD
Bumetanide—PTGS2—Disease—PKLR—malaria	3.68e-05	0.000668	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism—HPGDS—malaria	3.47e-05	0.000629	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—HBB—malaria	3.46e-05	0.000627	CbGpPWpGaD
Bumetanide—PTGS2—Disease—G6PD—malaria	3.28e-05	0.000595	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism—DHFR—malaria	3.22e-05	0.000584	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism—SCARB1—malaria	3.19e-05	0.000578	CbGpPWpGaD
Bumetanide—PTGS2—Spinal Cord Injury—IL6—malaria	3.14e-05	0.00057	CbGpPWpGaD
Bumetanide—CA9—Metabolism—CD36—malaria	3.13e-05	0.000568	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—PKLR—malaria	3.08e-05	0.000559	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—G6PD—malaria	2.75e-05	0.000498	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism of lipids and lipoproteins—CD36—malaria	2.71e-05	0.000492	CbGpPWpGaD
Bumetanide—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—malaria	2.65e-05	0.000481	CbGpPWpGaD
Bumetanide—PTGS2—Disease—DHFR—malaria	2.32e-05	0.000421	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—HPGDS—malaria	2.1e-05	0.00038	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism—CD36—malaria	2e-05	0.000363	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—DHFR—malaria	1.94e-05	0.000353	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—SCARB1—malaria	1.92e-05	0.000349	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—CD36—malaria	1.21e-05	0.000219	CbGpPWpGaD
Bumetanide—PTGS2—Disease—NOS2—malaria	1.19e-05	0.000215	CbGpPWpGaD
Bumetanide—PTGS2—Disease—CD4—malaria	8.78e-06	0.000159	CbGpPWpGaD
Bumetanide—PTGS2—Disease—IL6—malaria	4.75e-06	8.61e-05	CbGpPWpGaD
